**This article has been corrected:** The authors requested the replacement of panel C of Figure 3 because they reversed the inscriptions on this panel.

This correction does not change the content of the publication. The corrected Figure 3 is provided below.

![**PL402 promotes the expression of MMP3 and MMP9 which are involved in the effect of PL402 on Aβ level modulation.**(**A**) The mRNA level of Aβ degradation enzymes (MMPs) in SK-N-SH cells treated by vehicle (0.1% DMSO) or PL402 at 100μM and 300μM for 24h. N=4. (**B**--**C**) Representative image of a western blot showing the expression of MMP3 and MMP9 in SK-N-SH cells after treatment with vehicle (0.1% DMSO), or PL402 at 100μM and 300μM for 24h. Actin was used as a loading control (**B**). (**C**) The quantification analysis of (**B**) using ImageJ. N=3. (**D**) The mRNA level of MMP3 and MMP9 in SK-N-SH cells with the infection of scrambled, MMP3 or MMP9 gene-specific shRNA. N=4. (**E**) The levels of total Aβ produced by SK-N-SH cells measured by ELISA after treatment with vehicle (0.1% DMSO) or PL402 at 100μM and 300μM for 24 h in the cells infected with scrambled, MMP3 or MMP9 gene-specific shRNA. N=4. (**F**) The total Aβ level in SK-N-SH cells with presence or absence of the PL402 for 24h after pretreatment with vehicle (0.1% DMSO), or 10μM MMP inhibitor (batimastat) for 1h. N=3. Data are presented as the mean ± SEM, n [\>]{.ul}3 independent experiments. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001 compared to the control of each group or the control of the shNC group. One-way ANOVA or two-way ANOVA followed by Bonferroni test.](aging-12-102898-g001){#f3}
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